Alemanya - alemany - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

aspen pharma trading limited (8134622) - melphalan - filmtablette - teil 1 - filmtablette; melphalan (00550) 2 milligramm

Àustria - alemany - AGES (Agentur für Gesundheit und Ernährungssicherheit)

aspen pharma trading limited - melphalan - melphalan

Alemanya - alemany - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

aspen pharma trading limited (8134622) - melphalan - pulver und lösungsmittel zur herstellung einer injektionslösung - teil 1 - trockensubstanz; melphalan (00550) 50 milligramm

Suïssa - alemany - Swissmedic (Swiss Agency for Therapeutic Products)

aspen pharma schweiz gmbh - melphalanum - filmtabletten - melphalanum 2 mg, cellulosum microcristallinum, crospovidonum, silica colloidalis anhydrica, magnesii stearas, Überzug: hypromellosum, macrogolum 400, e 171, pro compresso obducto. - zytostatikum - synthetika

Bèlgica - alemany - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

aspen pharma trading - melphalan - pulver und lösungsmittel zur herstellung einer infusionslösung - 50 mg - melphalan 50 mg - melphalan

Suïssa - alemany - Swissmedic (Swiss Agency for Therapeutic Products)

aspen pharma schweiz gmbh - melphalanum - pulver und lösungsmittel zur herstellung einer injektions-/infusionslösung - praeparatio cryodesiccata: melphalanum 50 mg, povidonum k 12, acidum hydrochloridum pro vitro. solvens: natrii citras dihydricus corresp. natrium 46.9 mg, propylenglycolum, ethanolum 96 per centum 0.52 ml, aqua ad iniectabile q.s. ad solutionem pro 10 ml. - zytostatikum - synthetika

Bèlgica - alemany - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

aspen pharma trading - melphalan - tablette - 2 mg - melphalan 2 mg - melphalan

Alemanya - alemany - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

glaxo wellcome gmbh & co. kg - melphalan - manteltabletten - melphalan 5.mg

Unió Europea - alemany - EMA (European Medicines Agency)

adienne s.r.l. s.u. - melphalan hydrochloride - multiple myeloma; hodgkin disease; lymphoma, non-hodgkin; precursor cell lymphoblastic leukemia-lymphoma; leukemia, myeloid, acute; neuroblastoma; ovarian neoplasms; hematopoietic stem cell transplantation - antineoplastische mittel - high-dose of phelinun used alone or in combination with other cytotoxic medicinal products and/or total body irradiation is indicated in the treatment of:multiple myeloma,malignant lymphoma (hodgkin, non-hodgkin lymphoma),acute lymphoblastic and myeloblastic leukemia,childhood neuroblastoma,ovarian cancer,mammary adenocarcinoma. phelinun in combination with other cytotoxic medicinal products is indicated as reduced intensity conditioning (ric) treatment prior to allogeneic haematopoietic stem cell transplantation (allo-hsct) in malignant haematological diseases in adults. phelinun in combination with other cytotoxic medicinal products is indicated as conditioning regimen prior to allogeneic haematopoietic stem cell transplantation in haematological diseases in the paediatric population as:myeloablative conditioning (mac) treatment in case of malignant haematological diseasesric treatment in case of non-malignant haematological diseases.

Àustria - alemany - AGES (Agentur für Gesundheit und Ernährungssicherheit)

koanaa healthcare spain - melphalanhydrochlorid -